Unknown

Dataset Information

0

Novel inhibitors of bacterial virulence: development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression.

ABSTRACT: Resistance to antibiotics is an increasingly dire threat to human health that warrants the development of new modes of treating infection. We recently identified 1 (CCG-2979) as an inhibitor of the expression of streptokinase, a critical virulence factor in Group A Streptococcus that endows blood-borne bacteria with fibrinolytic capabilities. In this report, we describe the synthesis and biological evaluation of a series of novel 5,6-dihydrobenzo[h]quinazolin-4(3H)-one analogs of 1 undertaken with the goal of improving the modest potency of the lead. In addition to achieving an over 35-fold increase in potency, we identified structural modifications that improve the solubility and metabolic stability of the scaffold. The efficacy of two new compounds 12c (CCG-203592) and 12k (CCG-205363) against biofilm formation in Staphylococcus aureus represents a promising additional mode of action for this novel class of compounds.

SUBMITTER: Yestrepsky BD 

PROVIDER: S-EPMC3605901 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Novel inhibitors of bacterial virulence: development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression.

Yestrepsky Bryan D BD   Xu Yuanxi Y   Breen Meghan E ME   Li Xiaoqin X   Rajeswaran Walajapet G WG   Ryu Jenny G JG   Sorenson Roderick J RJ   Tsume Yasuhiro Y   Wilson Michael W MW   Zhang Wenpeng W   Sun Duxin D   Sun Hongmin H   Larsen Scott D SD  

Bioorganic & medicinal chemistry 20130201 7

Resistance to antibiotics is an increasingly dire threat to human health that warrants the development of new modes of treating infection. We recently identified 1 (CCG-2979) as an inhibitor of the expression of streptokinase, a critical virulence factor in Group A Streptococcus that endows blood-borne bacteria with fibrinolytic capabilities. In this report, we describe the synthesis and biological evaluation of a series of novel 5,6-dihydrobenzo[h]quinazolin-4(3H)-one analogs of 1 undertaken wi  ...[more]

Similar Datasets

Unknown Synthesis and Evaluation of Antioxidant Properties of 2-Substituted Quinazolin-4(3H)-ones.
| S-EPMC8588455 | biostudies-literature
Unknown Quinazolin-4(3<i>H</i>)-ones and 5,6-Dihydropyrimidin-4(3<i>H</i>)-ones from ?-Aminoamides and Orthoesters.
| S-EPMC6278269 | biostudies-literature
Unknown The PIFA-initiated oxidative cyclization of 2-(3-butenyl)quinazolin-4(3H)-ones - an efficient approach to 1-(hydroxymethyl)-2,3-dihydropyrrolo[1,2-a]quinazolin-5(1H)-ones.
| S-EPMC8630437 | biostudies-literature
Unknown Facile synthesis and herbicidal evaluation of 4H-3,1-benzoxazin-4-ones and 3H-quinazolin-4-ones with 2-phenoxymethyl substituents.
| S-EPMC6268642 | biostudies-literature
Unknown Synthesis and biofilm inhibition studies of 2-(2-amino-6-arylpyrimidin-4-yl)quinazolin-4(3H)-ones.
| S-EPMC7704793 | biostudies-literature
Unknown Allele substitution of the streptokinase gene reduces the nephritogenic capacity of group A streptococcal strain NZ131.
| S-EPMC97243 | biostudies-literature
Unknown 2,3-Di-methyl-quinazolin-4(3H)-one.
| S-EPMC4120575 | biostudies-literature
Unknown Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infection.
| S-EPMC5603603 | biostudies-literature
Unknown Identification and Preliminary Structure-Activity Relationship Studies of 1,5-Dihydrobenzo[e][1,4]oxazepin-2(3H)-ones That Induce Differentiation of Acute Myeloid Leukemia Cells In Vitro.
| S-EPMC8588310 | biostudies-literature
Unknown Selection, recombination, and virulence gene diversity among group B streptococcal genotypes.
| S-EPMC2725619 | biostudies-literature